Mara Beveridge, MD
- Director, Pigmented Lesions and Melanoma Surveillance, UH Cleveland Medical Center
- Director, Supportive Oncodermatology, UH Cleveland Medical Center
- Assistant Professor, CWRU School of Medicine
3000 Auburn Dr
Beachwood, OH 44122
Mara Beveridge, MD is Director of Supportive Oncodermatology and Director of the Pigmented Lesions and Melanoma Surveillance within the Department of Dermatology at University Hospitals. She is also a member of University Hospitals’ Multidisciplinary Cutaneous Oncology Conference. Her clinical interests include managing and caring for patients experiencing skin-related side effects to their cancer treatments. She works closely with colleagues at UH Seidman Cancer Center to coordinate the care of these complex patients. She also sees patients who are high risk for melanoma for routine skin monitoring and prevention in addition to her general dermatology practice.
Dr. Beveridge joined the department in 2018 and is a board-certified M.D. and a fellow of the American Academy of Dermatology. Dr. Beveridge completed her dermatology training at the University of Chicago where she was Chief Resident. She is a graduate of the University of Chicago Pritzker School of Medicine. Dr. Beveridge completed her internship at the University of Chicago as well.
Dr. Beveridge is involved in research and is a member of the Multinational Association of Supportive Care in Cancer. She has been invited to deliver lectures both locally and nationally. She is published in such peer-reviewed journals as the Journal of the American Academy of Dermatology and Supportive Care in Cancer. She enjoys working with and mentoring residents and medical students.
- General Dermatology
- Skin Toxicities of Anti-cancer Therapy
Research & Publications
Certifications & Memberships
- Dermatology - American Board of Dermatology
Residency | Dermatology
Dermatology - University Of Chicago Medical Center (2012 - 2015)
Internship | Internal Medicine
Internal Medicine - University Of Chicago Medical Center (2011 - 2012)
University Of Chicago Pritzker School Of Medicine (2011)
University Of Pennsylvania (2007)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Mara Beveridge did not disclose any Outside Relationships with Industry.